Is PureTech Health (LON:PRTC) Using Debt Sensibly?
Nov 15
Have your own idea? Try our Stock Screener
U.K. (FTSE) Biotech Industry Analysis
UpdatedNov 17, 2024
DataAggregated Company Financials
Companies22
- 7D-2.5%
- 3M-5.0%
- 1Y-21.1%
- YTD-21.0%
Over the last 7 days, the Biotech industry has dropped 2.5%, driven by Genus declining 7.5%. On the other hand PureTech Health is actually up 9.4%. Overall the industry is down 21% in 12 months. Earnings are forecast to grow by 37% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 17 Nov 2024 | UK£2.7b | UK£841.1m | -UK£294,635,028.92 | 83.8x | -9.1x | 3.2x |
| Tue, 15 Oct 2024 | UK£2.9b | UK£840.2m | -UK£295,599,113.82 | 97.1x | -10x | 3.5x |
| Thu, 12 Sep 2024 | UK£2.9b | UK£832.5m | -UK£314,474,713.82 | 92x | -9.1x | 3.4x |
| Sat, 10 Aug 2024 | UK£2.6b | UK£838.2m | -UK£257,848,172.08 | 30.2x | -10.2x | 3.1x |
| Mon, 08 Jul 2024 | UK£2.6b | UK£835.5m | -UK£260,519,230.39 | 30.5x | -10.1x | 3.2x |
| Wed, 05 Jun 2024 | UK£3.0b | UK£837.0m | -UK£285,185,496.43 | 30.9x | -10.5x | 3.6x |
| Fri, 03 May 2024 | UK£2.9b | UK£836.7m | -UK£304,498,272.12 | 30.5x | -9.5x | 3.5x |
| Sun, 31 Mar 2024 | UK£3.1b | UK£903.1m | -UK£202,203,282.48 | 28.6x | -15.2x | 3.4x |
| Tue, 27 Feb 2024 | UK£3.2b | UK£896.6m | -UK£197,636,589.15 | 32x | -16.4x | 3.6x |
| Thu, 25 Jan 2024 | UK£6.5b | UK£1.3b | -UK£245,236,799.00 | 38.8x | -26.3x | 5.1x |
| Sat, 23 Dec 2023 | UK£6.3b | UK£1.3b | -UK£245,166,674.00 | 38x | -25.7x | 5x |
| Mon, 20 Nov 2023 | UK£6.4b | UK£1.3b | -UK£246,474,054.00 | 38.6x | -25.9x | 5x |
| Wed, 18 Oct 2023 | UK£6.5b | UK£1.3b | -UK£251,049,349.00 | 38.4x | -25.9x | 5.1x |
| Fri, 15 Sep 2023 | UK£6.6b | UK£1.3b | -UK£207,212,895.00 | 23.1x | -31.7x | 5.1x |
| Sun, 13 Aug 2023 | UK£6.7b | UK£1.3b | -UK£208,032,536.00 | 23.6x | -32.4x | 5.4x |
| Tue, 11 Jul 2023 | UK£6.7b | UK£1.3b | -UK£208,522,433.00 | 23.9x | -32.3x | 5.3x |
| Thu, 08 Jun 2023 | UK£7.0b | UK£1.3b | -UK£206,038,256.00 | 23.3x | -34x | 5.6x |
| Sat, 06 May 2023 | UK£7.1b | UK£1.3b | -UK£205,609,959.00 | 23.6x | -34.6x | 5.7x |
| Mon, 03 Apr 2023 | UK£7.2b | UK£1.2b | -UK£154,258,301.00 | 24.3x | -46.5x | 5.8x |
| Wed, 01 Mar 2023 | UK£7.5b | UK£1.2b | -UK£156,605,041.00 | 25.9x | -48.1x | 6.1x |
| Fri, 27 Jan 2023 | UK£7.5b | UK£1.2b | -UK£146,393,475.00 | 26.6x | -51x | 6.4x |
| Sun, 25 Dec 2022 | UK£7.5b | UK£1.2b | -UK£138,559,947.00 | 26.9x | -53.9x | 6.4x |
| Tue, 22 Nov 2022 | UK£7.8b | UK£1.2b | -UK£140,602,326.00 | 25.1x | -55.3x | 6.7x |
| Thu, 20 Oct 2022 | UK£7.0b | UK£1.2b | -UK£150,598,744.00 | 26.2x | -46.6x | 6x |
| Sat, 17 Sep 2022 | UK£7.7b | UK£1.2b | -UK£178,011,449.00 | 26x | -43.5x | 6.7x |
| Mon, 15 Aug 2022 | UK£7.5b | UK£1.1b | -UK£200,888,849.00 | 38x | -37.4x | 6.7x |
| Wed, 13 Jul 2022 | UK£6.9b | UK£1.1b | -UK£175,738,210.00 | 34.7x | -39.1x | 6.2x |
| Fri, 10 Jun 2022 | UK£7.0b | UK£1.1b | -UK£157,224,393.00 | 36.6x | -44.8x | 6.3x |
| Sun, 08 May 2022 | UK£6.8b | UK£1.1b | -UK£144,620,420.00 | 33.4x | -47.1x | 6.1x |
| Tue, 05 Apr 2022 | UK£7.5b | UK£1.1b | -UK£87,647,971.00 | 42.1x | -85.2x | 6.8x |
| Thu, 03 Mar 2022 | UK£7.8b | UK£1.1b | -UK£132,338,178.00 | 35.6x | -59.3x | 7.2x |
| Sat, 29 Jan 2022 | UK£9.0b | UK£1.1b | -UK£119,749,594.00 | 37.6x | -75.2x | 8.3x |
| Mon, 27 Dec 2021 | UK£11.3b | UK£1.1b | -UK£120,910,006.00 | 55.9x | -93.9x | 10.4x |
| Wed, 24 Nov 2021 | UK£11.5b | UK£1.1b | -UK£122,888,812.00 | 63.6x | -93.3x | 10.6x |
Price to Earnings Ratio
-93.3x
Current Industry PE
- Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 6.1x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 8.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.14% | |
| Healthcare | -0.52% | |
| Biotech | -2.46% | |
| Biotech | -2.46% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PRTC PureTech Health | UK£1.72 | 9.4% +UK£35.4m | -0.3% | PS1106.7x | |
| SCLP Scancell Holdings | UK£0.16 | 18.2% +UK£23.2m | 27.5% | PE-25.8x | |
| BVXP Bioventix | UK£38.25 | 3.4% +UK£6.5m | 2.0% | PE24.7x | |
| 4BB 4basebio | UK£13.25 | 3.9% +UK£6.4m | 150.0% | PS284.7x | |
| OPTI OptiBiotix Health | UK£0.14 | 8.0% +UK£979.4k | -51.8% | PS23.2x |
